Acantholytic Pityriasis Rubra Pilaris Associated with Imiquimod 3.75% Application

Links shared publicly online about this topic.

0
total visits

Acantholytic Pityriasis Rubra Pilaris Associated with Imiquimod 3.75% Application

Imiquimod is an immunomodulator with both antitumor and antiviral properties. It is currently available in two cream formulations as Aldara (imiquimod 5%) and the newly approved Zyclara (imiquimod 3.75%). Imiquimod has been associated with localized erythema, crusting, and scaling at the site of application. However, more severe generalized skin eruptions including erythema multiforme, psoriasis, and hyperpigmentation have been described. The newly approved imiquimod 3.75% cream is a presumably

View full resource at hindawi.com

Tags: Skin, Psoriasis, Dairy